Heart failure market to be valued at $53 bn by 2032 across 7MM: GlobalData forecast

The pressure for pharmaceutical companies to be more innovative with their therapies and tackle unmet needs is increasing. Companies are approaching the HF market with the strategies of optimising treatment safety and compliance, as well as developing novel drug classes: Kajal Jaddoo

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zBAUNSo
via